Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

QUOTED. 17 April 2020. Ricki Chase.

Executive Summary

Last month the FDA hit the pause button on in-person inspections as the coronavirus pandemic rolls on, but the agency can still perform paper “desk audits.” We spoke to Ricki Chase, compliance practice director, Lachman Consultant Services, about the process.

“If they’re subjecting you to a desk audit, you do not want to ask for an extension. You do not want to delay. The impression that gives is terrible.” – Ricki Chase, compliance practice director, Lachman Consultant Services

Click here for a free trial of Medtech Insight

Related Content

Topics

UsernamePublicRestriction

Register

LL026487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel